Skip to main content
Equibles

VANGUARD CAPITAL MANAGEMENT LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 2100119 MALVERN, PA
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,861,942
-$1,281,580 QoQ
Shares Held
9,054,918
+8.9% QoQ
Ownership
3.58%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 130 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VANGUARD CAPITAL MANAGEMENT LLC holds $43,385,068,026 across 465 Biotechnology names. LCTX ranks #211 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 16,580,713 $8,236,137,568
2 REGN
Regeneron Pharmaceuticals, Inc.
 6,629,759 $4,133,919,926
3 ALNY
Alnylam Pharmaceuticals, Inc.
 6,029,478 $1,815,053,762
4 RVMD
Revolution Medicines, Inc.
 9,088,661 $1,702,124,432
5 MRNA
Moderna, Inc.
 23,208,792 $1,625,311,703
6 INCY
Incyte Corp
 11,024,289 $1,249,713,401
7 INSM
INSMED Inc
 9,790,865 $1,043,902,026
8 ROIV
Roivant Sciences Ltd.
 22,123,198 $782,939,977

All Filings in LCTX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,861,942 9,054,918
2026-03-31 $13,143,522 8,318,685